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Globally, approximately 12% of the population is inflicted by various types of urolith-
iasis. Standard treatments are available both to avert and treat urolithiasis, but with 
significant adverse side effects. Pentacyclic triterpenes represent a group of 
naturally occurring compounds which holds immense potential as therapeutic for 
treating kid-ney stone. This review aims to provide an integrative description on 
how pentacyclic triterpenes can effectively treat calcium oxalate urolithiasis through 
various mecha-nisms such as antioxidant, anti-inflammatory, diuretic, and 
angiotensin-converting enzyme inhibition. Some of the pentacylic triterpenes which 
shows promising activi-ties include lupeol, oleanolic acid, betulin, and taraxasterol. 
Moreover, future perspec-tives in the development of pentacyclic triterpenes in 
formulations/drugs for urinary stone prevention are highlighted. It is anticipated that 
compiled information would serve as a scientific baseline to advocate further 
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